Welcome to our dedicated page for Republic Tech news (Ticker: DOCKF), a resource for investors and traders seeking the latest updates and insights on Republic Tech stock.
Republic Technologies Inc. (OTCQB: DOCKF; CSE: DOCT) generates news that centers on its Ethereum-based infrastructure, financing activities, and institutional partnerships. As a publicly traded technology company with an ETH-denominated treasury, Republic regularly issues updates on how it acquires and deploys ETH into validator infrastructure to support its attestation-focused business model.
Recent news releases describe the company’s drawdown of a secured convertible note facility of up to US$100 million, including a first US$10 million tranche, and how net proceeds are intended to be used primarily to purchase ETH for validator operations and attestation services. The company has also reported additional ETH acquisitions and discussed its use of Synthetic Mining strategies to expand ETH holdings and support infrastructure growth.
Readers following DOCKF news will see coverage of Republic’s capital markets developments, such as its OTCQB listing in the United States, DTC eligibility, and ongoing trading on the Canadian Securities Exchange and Frankfurt Stock Exchange. Governance and corporate updates, including annual meeting results, adoption of an Advance Notice Policy, and board and management appointments, are also key themes in its disclosures.
Another important stream of news involves Republic’s partnerships with institutional digital asset platforms. The company has announced strategic relationships with BitGo for custody-integrated staking, FalconX for ETH liquidity and execution, and Fireblocks for custody, governance, and risk controls. Together, these updates provide insight into how Republic is building the infrastructure, security, and financing base for its Ethereum validator and attestation platform. Investors and observers can use this news feed to monitor the company’s progress in treasury management, infrastructure deployment, and corporate governance.
Republic Technologies (CSE: DOCT) held its Annual General and Special Meeting of Shareholders on August 19, 2025, where shareholders approved all proposed matters. The company's shareholders elected four directors to the board: Daniel Liu, Hongming Luo, Tianrui Zhang, and Litong Cao.
Additionally, shareholders appointed Charlton & Company, CPA as the company's auditor and approved a new 20% rolling long-term incentive plan. The meeting also resulted in the approval of deleting and replacing the Company's Articles, which are available on SEDAR+.
Republic Technologies (CSE: DOCT) has announced a strategic partnership with BitGo Trust Company to secure its Ethereum operations and digital asset treasury. BitGo, a leading digital asset infrastructure provider, offers regulated custody services across 90+ countries with up to $250 million in insurance coverage for cold storage assets.
The partnership will enable Republic to leverage BitGo's custody-integrated staking infrastructure for generating rewards on ETH treasury assets while maintaining assets in segregated cold storage. BitGo's infrastructure is certified under SOC 1 Type 2 and SOC 2 Type 2 standards, providing institutional-grade security and regulatory compliance.
Republic Technologies (CSE: DOCT) has announced a strategic integration with Kraken, a leading digital asset exchange, to enhance its Ethereum infrastructure operations. The partnership will support Republic's attestation and validator operations through Kraken's institutional infrastructure.
Kraken, established in 2011, operates in over 190 countries with regulatory oversight across multiple jurisdictions and maintains SOC 2 Type II certification. Republic will utilize Kraken's platform to streamline treasury deployment for its validator operations, which are crucial for their proprietary attestation platform that generates on-chain proofs for data verification in decentralized systems.
Beyond Medical Technologies (CSE: DOCT) has announced its corporate name change to Republic Technologies Inc., effective July 15th, 2025. The company's common shares will maintain their trading symbol "DOCT" on the Canadian Securities Exchange, with a new CUSIP (760801100) and ISIN (CA7608011002).
Republic Technologies focuses on developing smart contract-based attestation products and operating Ethereum validators through ETH staking. The company maintains ETH as its primary treasury asset and aims to expand its holdings alongside infrastructure growth. The new name reflects the company's commitment to decentralization, transparency, and democratized access to secure systems.
Beyond Medical Technologies (OTC:DOCKF) reported significant progress in H1 2025 and announced its transformation into Republic Technologies, positioning itself to become Canada's first public company integrating Ethereum infrastructure as a core operational component.
Key developments include: raising CAD $3.45 million through various financings, launching a dedicated treasury division for ETH management, and securing strategic partnerships with BitGo and Fireblocks for digital asset custody. The company has expanded its attestation platform beyond healthcare to support sector-agnostic use cases and is preparing to launch its Early-Access Attestation Dashboard for enterprise clients.
The company's transformation includes adopting Ethereum infrastructure for its platform operations, treasury strategy, and validator infrastructure, aligning with major institutions like BlackRock, PayPal, and JPMorgan Chase.
Beyond Medical Technologies (OTC: DOCKF) has received acceptance from the British Columbia Securities Commission (BCSC) for its management cease trade order (MCTO) application. The MCTO, effective May 1, 2025, relates to a delay in filing the company's 2024 annual financial statements and related documentation. The delay is attributed to a recent management team transition. The company expects to complete the Annual Filings by June 30, 2025 and will comply with alternative information guidelines, including bi-weekly default status updates.
Beyond Medical Technologies (CSE: DOCT, OTC: DOCKF) has announced it will likely miss the April 30, 2025 deadline for filing its annual financial statements and related documents for the fiscal year ended December 31, 2024. The company has applied for a Management Cease Trade Order (MCTO) with the British Columbia Securities Commission due to delays caused by a recent management team transition.
The company expects to complete the Annual Filings by June 30, 2025. During the MCTO period, public trading of shares will continue, but company executives and certain insiders will be restricted from trading. Beyond Medical will issue bi-weekly status updates and comply with alternative information guidelines under National Policy 12-203.
Beyond Medical Technologies (CSE: DOCT, OTC: DOCKF) has announced significant corporate changes and strategic initiatives. The company implemented a complete executive leadership refresh in February 2025, appointing Daniel Liu as CEO, along with new directors and officers including Hongming Luo, Steven McAuley, Stevenson Ty as CFO, and Litong Cao as COO.
The company entered a licensing agreement with Ethsign for blockchain software, paying $25,000 through 192,308 shares at $0.13 per share. Beyond Medical is developing a blockchain attestation system for medical recordkeeping using Ethereum as its foundation.
Financially, the company has settled $395,000 of debt through share issuance and completed a $375,000 private placement, maintaining a current cash balance of CAD $172,018. The company aims to integrate blockchain-based attestations for medical record verification by Q2 2025. The previously announced Elite Horizon acquisition has been terminated.
Beyond Medical Technologies (CSE: DOCT, OTC: DOCKF) has announced a non-binding letter of intent to acquire Elite Horizon Management, a blockchain attestation platform specializing in secure documentation and financial verification. The proposed share exchange transaction would involve issuing up to 11,250,000 common shares to Horizon shareholders.
The acquisition aims to integrate blockchain technology for enhanced efficiency, security, and transparency in medical operations, focusing on smart contract verification and treasury management solutions. The deal is subject to due diligence, definitive agreement execution by March 31, 2025, and regulatory approvals.
Additionally, Beyond Medical has engaged Fairfax Partners for investor relations services, with a CAD $35,000 setup fee, CAD $7,500 monthly management fee, and CAD $50,000 marketing budget for a 12-month period.
Beyond Medical Technologies (CSE: DOCT, OTC: DOCKF) has announced three significant developments: First, the company has successfully repaid 68.7% of its outstanding debt by issuing 7.9 million common shares at $0.05 per share to settle $395,000 of debt obligations. Second, Steven McAuley has been appointed to the Board of Directors, bringing decades of experience in corporate governance and operational strategy. Third, Stevenson Ty has been named Interim Chief Financial Officer, replacing Jatin Baski. Ty brings extensive experience in corporate finance, treasury management, and regulatory compliance from previous executive finance roles.